$EUDA

EUDA Health faced a significant downgrade as Greenridge lowered its price target from $6 to $2.75. This action reflects concerns about the company's valuation and future performance. Analysts may be reacting to recent financial disclosures and market conditions. The reduced target price suggests a bearish outlook for EUDA Health's stock in the near term. Investors may need to reevaluate their positions based on this new information.